(Q40395715)

20 September 2017

1 reference

title

Choosing the right beta-blocker. A guide to selection (English)

1 reference

20 September 2017

J R Hampton

1

1 reference

20 September 2017

publication date

1 October 1994

1 reference

20 September 2017

1 reference

20 September 2017

volume

48

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

549-568

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199448040-00005

20 September 2017

exact match

0 references

cites work

Effect of oxprenolol on ventricular arrhythmias: the European Infarction Study experience

1 reference

12 December 2020

Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol

1 reference

12 December 2020

1 reference

12 December 2020

Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo

1 reference

12 December 2020

Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol.

1 reference

12 December 2020

GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico

1 reference

12 December 2020

Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group

1 reference

12 December 2020

Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups

1 reference

12 December 2020

Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group

1 reference

12 December 2020

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

12 December 2020

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

12 December 2020

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

12 December 2020

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

1 reference

12 December 2020

Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group

1 reference

12 December 2020

Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg

1 reference

12 December 2020

A comparison of carvedilol with atenolol in the treatment of mild-to-moderate essential hypertension. INT-CAR-07 (U.K.) Study Group

1 reference

12 December 2020

Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction

1 reference

12 December 2020

Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group

1 reference

12 December 2020

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study

1 reference

12 December 2020

Celiprolol in systemic hypertension

1 reference

12 December 2020

Beta blockers in heart failure

1 reference

12 December 2020

Usefulness of bucindolol in congestive heart failure

1 reference

12 December 2020

Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

1 reference

12 December 2020

Controlled trial of sotalol for one year after myocardial infarction

1 reference

12 December 2020

European Infarction Study (E.I.S.). A secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality

1 reference

12 December 2020

Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg

1 reference

12 December 2020

One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial

1 reference

12 December 2020

Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group

1 reference

12 December 2020

Beta-blockers in heart failure: promising or proved?

1 reference

12 December 2020

Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity

1 reference

12 December 2020

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Carvedilol (Kredex&reg;) Reduces Infarct Size in a Canine Model of Acute Myocardial Infarction

1 reference

12 December 2020

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

12 December 2020

Torsades de pointes and proarrhythmia

1 reference

12 December 2020

Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy.

1 reference

12 December 2020

Beta-blocking agents with vasodilating action

1 reference

12 December 2020

Sotalol: a novel beta-blocker with class III anti-arrhythmic activity

1 reference

12 December 2020

Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results

1 reference

12 December 2020

Efficacy of sotalol in controlling reentrant supraventricular tachycardias.

1 reference

12 December 2020

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)

1 reference

12 December 2020

Determination of the anti-ischemic activity of nebivolol in comparison with atenolol

1 reference

12 December 2020

Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction

1 reference

12 December 2020

Randomised trial of treatment of hypertension in elderly patients in primary care

1 reference

12 December 2020

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

12 December 2020

Metabolic and cardiovascular benefits deriving from beta-adrenergic blockade in chronic congestive heart failure

1 reference

12 December 2020

Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis

1 reference

12 December 2020

A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

1 reference

12 December 2020

Trial of propranolol in acute myocardial infarction.

1 reference

12 December 2020

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

12 December 2020

Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension

1 reference

12 December 2020

The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure

1 reference

12 December 2020

Which Ancillary Properties of Beta-Adrenoceptor Blocking Drugs Influence Their Therapeutic or Adverse Effects?: A Review

1 reference

12 December 2020

Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. The German and Austrian Xamoterol Study Group

1 reference

12 December 2020

The Australian therapeutic trial in mild hypertension. Report by the Management Committee

1 reference

12 December 2020

An early intervention secondary prevention study with oxprenolol following myocardial infarction

1 reference

12 December 2020

Efficacy and safety of sotalol in patients with complex ventricular arrhythmias

1 reference

12 December 2020

Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia

1 reference

12 December 2020

Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial

1 reference

12 December 2020

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

1 reference

12 December 2020

Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

1 reference

12 December 2020

Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketan

1 reference

12 December 2020

Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study

1 reference

12 December 2020

Ventricular tachycardia

1 reference

12 December 2020

HYPOTENSIVE ACTION OF PRONETHALOL.

1 reference

12 December 2020

Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results

1 reference

12 December 2020

Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger

1 reference

12 December 2020

A long-term prevention study with oxprenolol in coronary heart disease

1 reference

12 December 2020

A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias

1 reference

12 December 2020

The effects of metoprolol given early in acute myocardial infarction on ventricular arrhythmias

1 reference

12 December 2020

Practolol in acute myocardial infarction

1 reference

12 December 2020

Beta-blocking agents vs. antiarrhythmic interventions in heart failure complicated by arrhythmias.

1 reference

12 December 2020

Effect of propranolol in myocardial infarction

1 reference

12 December 2020

How Do Beta-Blockers Protect After Myocardial Infarction?

1 reference

12 December 2020

Newer beta blockers and the treatment of hypertension

1 reference

12 December 2020

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

12 December 2020

Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction.

1 reference

12 December 2020

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

12 December 2020

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

12 December 2020

Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy

1 reference

12 December 2020

Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy

1 reference

12 December 2020

Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

A NEW ADRENERGIC BETARECEPTOR ANTAGONIST

1 reference

12 December 2020

Comparison of class I and class III action in atrial fibrillation

1 reference

12 December 2020

Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy

1 reference

12 December 2020

Clinical safety and efficacy of celiprolol

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Carvedilol inhibits vascular smooth muscle cell proliferation.

1 reference

12 December 2020

Improvement in exercise performance and hemodynamics by labetalol in patients with idiopathic dilated cardiomyopathy.

1 reference

12 December 2020

Formulary considerations in selection of beta-blockers

1 reference

12 December 2020

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

12 December 2020

Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction

1 reference

12 December 2020

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

1 reference

12 December 2020

The effect of pindolol on the two years mortality after complicated myocardial infarction

1 reference

12 December 2020

Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction

1 reference

12 December 2020

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

12 December 2020

A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias

1 reference

12 December 2020

USE OF PROPRANOLOL IN ANGINA PECTORIS

1 reference

12 December 2020

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

12 December 2020

Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy

1 reference

12 December 2020

Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide)

1 reference

12 December 2020

10.2165/00003495-199448040-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1038971914

0 references

1 reference